datopotamab,SKB264
merck,daiichi sankyo,astrazeneca,gilead,klus
['datopotamab', '$gild', '$dsnky', '$azn', '$mrk']
so here are those $mrk trop2 adc data (actually kelun's data). nb: egfrm/wt split is key to comparing across trials vs datopotamab $dsnky $azn $gild via wenfeng fang #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.